Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection.
Marelli
C
C
Nycomed Amersham, Nycomed Imaging AS, Clinical R& D, P. O. Box 4220 Torshov, N-0401 Oslo, Norway.
D000818:Animals; D001783:Blood Flow Velocity; D002986:Clinical Trials as Topic; D003287:Contrast Media; D003326:Coronary Circulation; D004341:Drug Evaluation; D004452:Echocardiography / Q000379:methods*; D005290:Ferric Compounds; D006352:Heart Ventricles / Q000000981:diagnostic imaging*; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron; D008099:Liver / Q000000981:diagnostic imaging* / Q000502:physiology; D008102:Liver Circulation; D010087:Oxides; D018608:Ultrasonography, Doppler / Q000379:methods*; D016276:Ventricular Function
D003287:Contrast Media; D005290:Ferric Compounds; D010087:Oxides; C069727:Sonazoid; D007501:Iron